Symposium
Structural Template for Neurodegeneration -From Network to Clinical Manifestations-
May 30 (Thu) 10:00-11:50 Room10 (G502)
- Chairs:
-
Shigeo Murayama
The Brain Bank for Aging Research of Tokyo Metropolitan Healthy Longevity Medical Center
Toshiki Uchihara
Laboratory of Structural Neuropathology, Tokyo Metropolitan Institute of Medical Science
Neuroanatomy of regional progression in the human brain and spinal cord
- Speaker:
-
Kelly Del Tredici-Braak
Clinical Neuroanatomy Section, Department of Neurology, Center for Biomedical Research, University of Ulm, Ulm, Germany
Axonal α-synuclein and dendritic tau: contrasting spreads in neurons
- Speaker:
-
Toshiki Uchihara
Laboratory of Structural Neuropathology,
Tokyo Metropolitan Institute of Medical Science
Transmission and propagation of tau pathology in transgenic mouse brain
- Speaker:
-
Markus Tolnay
Institute of Pathology, Basel University Hospital, Basel, Switzerland
Spread of TDP-43 pathology in non-human primate model of ALS
- Speaker:
-
Takanori Yokota
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
Basics of Epilepsy Treatment and Advances of Seizure Focus Localization
May 31 (Fri) 13:30-15:20 Room6 (Hall B5 (2))
- Chairs:
-
Sadatoshi Tsuji
International University of Health and Welfare
Akio Ikeda
Department of Neurology,
Kyoto University Hospital and Graduate School of Medicine
Current antiepileptic treatment in women of child-bearing age
- Speaker:
-
Torbjörn Tomson
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Routine scalp EEG: The diagnostic role in epilepsy
- Speaker:
-
Ayumu Onuma
Department of Neurology, Kohnan Hospital
Usefulness of long term video EEG monitoring and factors for consideration
- Speaker:
-
Hiroshi Shigeto
Fukuoka Sanno Hospital
Progress in functional neuroimaging of epilepsy
- Speaker:
-
Hiroshi Matsuda
Integrative Brain Imaging Center, National Center of Neurology and Psychiatry
The role of neuropsychological examinations
- Speaker:
-
Mitsuhiko Yamano
Central Japan Railway Company, Shizuoka Health Care Center
Pathogenesis and Treatment of NMO
May 31 (Fri) 13:30-15:20 Room7 (Hall D7)
- Chairs:
-
Yasuto Itoyama
National Center Hospital, National Center of Neurology and Psychiatry
Makoto Matsui
Department of Neurology, Kanazawa Medical University
Clinical spectrum of NMO: How broad is it?
- Speaker:
-
Brian G. Weinshenker
Department of Neurology, Mayo Clinic, Rochester MN, USA
Neuropathology of NMO: a nosological consideration
- Speaker:
-
Kazuo Fujihara
Department of MS Therapeutics, Tohoku University Graduate School of Medicine
NMO pathogenesis mechanisms and new therapeutic approaches
- Speaker:
-
Alan S. Verkman
University of California, San Francisco, USA
The role of IL-6 dependent plasmablasts in the pathogenesis of NMO
- Speaker:
-
Takashi Yamamura
Department of Immunology, National Institute of Neuroscience, NCNP
Gene Silencing Therapy for Neurological Diseases
May 31 (Fri) 13:30-15:20 Room9 (Hall D1)
- Chairs:
-
Beverly L. Davidson
Department of Neurology, University of Iowa, USA
Shinichi Takeda
National Center of Neurology and Psychiatry
RNAi medicine for the brain
- Speaker:
-
Beverly L. Davidson
University of Iowa, Iowa, USA
Advances in RNA interference (RNAi) therapeutics
- Speaker:
-
Muthiah Manoharan
Alnylam Pharmaceuticals, Cambridge, MA, USA
Antisense oligonucleotide therapies for the treatment of neurodegenerative diseases
- Speaker:
-
C. Frank Bennett
Isis Pharmaceuticals Inc., USA
A new class of oligonucleotide drug
- Speaker:
-
Takanori Yokota
Department of Neurology and Neurological Science, Tokyo Medical and Dental University
Recent Progress in Multiple System Atrophy
May 31 (Fri) 13:30-15:20 Room13 (G701)
- Chairs:
-
Hideki Mochizuki
Department of Neurology, Osaka University Graduate School of Medicine
Atsushi Takeda
Department of Neurology, Tohoku University School of Medicine
Pathogenesis of multiple system atrophy
- Speaker:
-
Takafumi Hasegawa
Department of Neurology, Tohoku University School of Medicine
Genetics from familial multiple system atrophy
- Speaker:
-
Jun Goto
Department of Neurology, The University of Tokyo Hospital
Neuroimaging of multiple system atrophy
- Speaker:
-
A. Jon Stoessl
The Pacific Parkinson's Research Centre and National Parkinson Foundation Centre of Excellence at UBC & Vancouver Coastal Health, Canada
Mesenchymal stem cells as a potential therapeutic candidate of multiple system atrophy
- Speaker:
-
Phil Hyu Lee
Department of Neurology, Yonsei University College of Medicine / Severance Biomedical Science Institute, Yonsei University, Seoul, Korea
Vascular Dementia and Its Associated Conditions -Vascular Cognitive Impairment (VCI)
June 1 (Sat) 8:00-9:50 Room6 (Hall B5 (2))
- Chairs:
-
Hidekazu Tomimoto
Department of Neurology, Mie University Graduate School of Medicine
Osamu Onodera
Department of Molecular Neuroscience, Resource Branch for Brain Disease, Brain Research Institute, Niigata University
Overview of the neuropathology of vascular cognitive disorders
- Speaker:
-
Raj N Kalaria
Institute for Ageing and Health, NIHR Biomedical Research Building, Newcastle University, Newcastle upon Tyne, UK
Chronic cerebral hypoperfusion and dementia
- Speaker:
-
Kenichiro Yata
Department of Neurology, Mie University Graduate School of Medicine
Cerebral amyloid angiopathy and cognitive impairment
- Speaker:
-
Masafumi Ihara
Department of Stroke and Cerebrovascular Diseases, National Cerebral and Cardiovascular Center
Vascular cognitive impairment (VCI) and gene
- Speaker:
-
Atsushi Watanabe
National Center for Geriatrics and Gerontology, Laboratory of Research Advancement
Subgroups of AD associated with diabetes mellitus based on brain imaging
- Speaker:
-
Haruo Hanyu
Department of Geriatric Medicine, Tokyo Medical University
Non-coding Repeat Expansion Disorders
June 1 (Sat) 8:00-9:50 Room9 (Hall D1)
- Chairs:
-
Kinji Ohno
Division of Neurogenetics, Nagoya University Graduate School of Medicine
Tohru Matsuura
Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Repeat-associated diseases, mutagenesis, pathogenesis, and therapeutic avenues
- Speaker:
-
Christopher E. Pearson
The Reasearch Institute, The Hospital for Sick Children, Toronto, Canada
Spinocerebellar ataxia type 31
- Speaker:
-
Kinya Ishikawa
Department of Neurology and Neurological Science,
Tokyo Medical and Dental University
Clinical features of novel ALS/SCA crossroad mutation Asidan (SCA36)
- Speaker:
-
Koji Abe
Department of Neurology, Okayama University
Found in translation: Novel disease mechanisms in Fragile X Tremor Ataxia Syndrome
- Speaker:
-
Peter K. Todd
The Bucky and Patti Harris Professor of Neurology, University of Michigan Medical School, USA
The expanded GGGGCC repeat in C9orf72 is translated into aggregating dipeptide-repeat proteins in FTLD/ALS
- Speaker:
-
Dieter Edbauer
Ludwig-Maximilians Universität München, Munich, Germany